Just realized that I started taking Peg in late September 2021...it has been quite a ride. Briefly: diagnosed with ET Jak2+ officially in Dec 2020 via BMB (but had high platelets and leukocytosis for 6-10 years prior to that). Allele burden of 40% (Jak2) and 4% TET2.
Had been on aspirin only and monitoring since 2014 (when my GP got two high platelet readings in a row and prescribed baby aspirin as a preventive measure (but interestingly enough did not refer me to a hematologist - would have to change doctors for that to happen). Even after Dx stayed on aspirin only regime until platelets shot up from about 900 to 1.400 and had bleeding at the gums. MPN specialist suggested, despite relatively young age (52) and no history of thrombosis, we start cytoreductive therapy. As is usually the case for ET, HU was first line medicine offered. Started on HU slowly and eventually worked my way up to 21 pills/week. Was starting to be effective in controlling blood counts but was too toxic for me personally.
Worked with MPN specialist to switch to Peg (which I had been keen on since the start as it seemed to be the only medicine currently out there that can possibly move us toward molecular remission / slow progression (I have always been worried about progression given the attributes of my particular case of ET).
Started at 180mcg/2 weeks. Worked almost immediately to help drop platelets (by about 100 every reading (so every month) and within about 5-6 months platelets were around 600 (our target) and all other readings (particularly WBC) were in line...but then got abnormal liver readings (very elevated AST and ALT although Bilirubin has always remained WNL). Discontinued Peg for 6 weeks - liver readings came back in line but both platelets and WBCs shot up.
Went back on Peg at half the previous dose - so 90cg/2 weeks. Seemed to be working well with blood numbers coming down but still evidencing liver sensitivity (the readings were elevated but not as bad at as at the peak) . At July 2022 reading my MPN specialist stated that "if we could freeze" my results forever we would be happy (platelets at 480; all other bloods WNL however liver still elevated (ALT a little less than 3x top of reference range and AST almost double - these are still much lower than the peak of ALT=4x and AST=3x).
Over this summer, travel and family plans meant I took the Peg (90mcg) every 3 weeks instead of every 2). I could have traveled with the Peg as I had in the past to maintain the every 2 weeks regimen ,but also wanted to see what would happen if we spread out the doses somewhat). So good news is that my liver function is fine on that dosing! AST WNL (at top of range but within) and ALT slightly elevated (very slightly). WBCs still in range as all other blood readings as well EXCEPT platelets jumped back up from 480 to 687...so what to do.
Met with my MPN specialist yesterday - I had suggested either perhaps going for a slightly higher dose (try to get 100 mcg every three weeks) or same 90 mcg at a different interval. After discussing it, we decided to maintain the 90mcg and try it at every 2.5 weeks (so every 17/18 days). We'll see if this maintains my liver in good stead but also brings platelets back down. As my MPN specialist stated: "platelets are important but so is your liver".
I am lucky that I have an MPN specialist that understands my key goals on treatment and QOL and is willing to work with me. Our plan, if the liver stays calm, would be to repeat the allele burden (most likely via BMB again) after being on an effective dose of Peg for a full year.
Happy that Peg works well for me. It had a very significant and almost immediate CHR with few if any side effects (well except for the liver...) - hoping if we can keep the liver in line (btw thyroid was also acting up slightly but was brought immediately into line with medication) then we'll remain on a maintenance dose of Peg for 12 months and re-test to see if there has been any molecular response.
Always reminded of how individual each of our MPN presentations are (as individual as we are) and how much trial and error is involved in trying to hit our individual "sweet spots".